Sudo Biosciences, Inc. — Form D/A
Sudo Biosciences, Inc. of CARMEL, IN, a company, filed a Form D amendment with the SEC on 2024-02-15. The offering totals $161.8M, of which $63.6M was reported sold. Industry: Other Technology.
Offering
- Filed: 2024-02-15
- Form: D/A
- Accession: 0001860521-24-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $161.8M
- Amount sold: $63.6M
- Remaining: $98.2M
- Investors: 15
- Date of first sale: 2023-12-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-501000
Issuer
- Name: Sudo Biosciences, Inc.
- CIK: 0001860521
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 10401 N. MERIDIAN STREET, CARMEL, IN, 46290
- Phone: 317-564-8990
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Scott Byrd | Director | Carmel, IN |
| Daniel Estes | Director | Carmel, IN |
| Edd Fleming | Director | Carmel, IN |
| Shinichiro Fuse | Director | Alameda, CA |
| Chris Gagliardi | Director | Carmel, IN |
| David Johnson | Director | Greenwood Village, CO |
| Scott Byrd | Executive Officer | Carmel, IN |
| Jim Bristol | Director | Menlo Park, CA |
| Bhaskar Chaudhuri | Director | Menlo Park, CA |
Other filings by this issuer (3)
More